Telomerase Activity in Human Breast Tumors
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The activity of the ribonucleoprotein enzyme telomerase is not detected in normal somatic cells; thus, with each cell division, the ends of chromosomes consisting of the telomeric repeats TTAGGG progressively erode. The current model gaining support is that telomerase activity in germline and immortal cells maintains telomere length and thus compensates for the "end-replication problem." PURPOSE: Our objective was to determine when telomerase activity is reactivated in the progression to malignant breast cancer and if knowledge of telomerase activity may be an indicator for the diagnosis and potential treatment of breast cancer. METHODS: Using a polymerase chain reaction-based telomerase activity assay, we examined telomerase activity in 140 breast cancer specimens (from 140 patients), four phyllodes tumors (from four patients), 38 noncancerous lesions (20 fibroadenomas, 17 fibrocystic diseases, one gynecomastia; from 38 patients), and 55 adjacent noncancerous mammary tissues (from 55 of the 140 breast cancer patients). In addition, 33 fine-needle-aspirated breast samples (from 33 patients) were analyzed. RESULTS: Among surgically resected samples, telomerase activity was detected in 130 (93%) of 140 breast cancers. Telomerase activity was detected in 68% of stage I primary breast cancers, in 73% of cancers smaller than 20 mm, and in 81% of axillary lymph node-negative cancers. Moreover, the activity was detected in more than 95% of advanced stage tumors but in only two (4%) of 55 adjacent noncancerous tissues. While telomerase activity was not detected in any of 17 specimens of fibrocystic disease, surprisingly low levels of telomerase activity were detected in nine (45%) of 20 fibroadenomas. Among samples obtained by fine-needle aspiration, 14 (100%) of 14 patients whose fine-needle-aspirated specimen contained telomerase activity and who subsequently underwent surgery were confirmed to have breast cancer. Multivariate analysis of 125 specimens from patients for whom data were available on age at surgery, stage of disease, tumor size, lymph node status tumor histology, and menopausal status indicated that stage classification exhibited the strongest association with telomerase activity (for stage I versus stages II-IV: odds ratio = 1.0 versus 73.4; 95% confidence interval = 2.0-959.0; P = .02). CONCLUSION: Telomerase activity was detected in more than 95% of advanced stage breast cancers. It was absent in 19%-32% of less advanced cancers. Since a determination of any association between telomerase activity and patient survival is not possible at the present time, it remains to be determined whether lack of telomerase activity predicts for favorable outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationIdentification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
Carter, C. L., Allen, C., & Henson, D. E. (1989) · Cancer · doi:10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h · Cited by 2,288
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · cited 1×
“Telomerase contains an RNA component that has a template region complementary to (TTAGGG)n repeats that permits the de novo synthesis of TTAGGG telomeric DNA onto chromosomal ends ( 17-19 ).”
BackgroundWATSON, J. D. (1972) · Nature New Biology · doi:10.1038/newbio239197a0 · Cited by 1,632 · cited 1×
“Lagging strand DNA synthesis at the very end of linear chromosomes cannot be completed (referred to as the "end-replication problem") and this situation results in the progressive shortening of telomeric repeats with each division ( 15 ,16).”
BackgroundMorin, G. B. (1989) · Cell · doi:10.1016/0092-8674(89)90035-4 · Cited by 1,495
Telomere loss: mitotic clock or genetic time bomb?
Harley, C. B. (1991) · Mutation Research/DNAging · doi:10.1016/0921-8734(91)90018-7 · Cited by 1,139
Telomere end-replication problem and cell aging
Levy, M. Z., Allsopp, R. C., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90096-3 · Cited by 1,069
Diagnostic Histopathology of the Breast
Page, D. L., & Anderson, T. J. (1988) · Medical Entomology and Zoology · Cited by 1,064
Richard, J., Sainsbury, C., Needham, G., Farndon, J., Malcolm, A., & Harris, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90593-9 · Cited by 892
Correlating telomerase activity levels with human neuroblastoma outcomes
Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., & Shay, J. W. (1995) · Nature Medicine · doi:10.1038/nm0395-249 · Cited by 611
Self-citationSTRUCTURE AND FUNCTION OF TELOMERES
Zakian, V. A. (1989) · Annual Review of Genetics · doi:10.1146/annurev.ge.23.120189.003051 · Cited by 609
Transient Increase in the Risk of Breast Cancer after Giving Birth
Lambe, M., Hsieh, C.-C., Trichopoulos, D., Ekbom, A., Pavia, M., & Adami, H.-O. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407073310102 · Cited by 591
Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L., & Holt, J. T. (1995) · Nature Genetics · doi:10.1038/ng0495-444 · Cited by 585
Long-Term Risk of Breast Cancer in Women with Fibroadenoma
Dupont, W. D., Page, D. L., Parl, F. F., Vnencak-Jones, C. L., Plummer, W. D., Rados, M. S., & Schuyler, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407073310103 · Cited by 500
Wright, W. E., Shay, J. W., & Piatyszek, M. A. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.18.3794 · Cited by 475
Self-citationIn vivo loss of telomeric repeats with age in humans
Lindsey, J., McGill, N. I., Lindsey, L. A., Green, D. K., & Cooke, H. J. (1991) · Mutation Research/DNAging · doi:10.1016/0921-8734(91)90032-7 · Cited by 463 · cited 1×
“While germline cells expressing telomerase activity maintain telomeric repeats, in somatic cells, progressive erosion of telomeres with each cell division is likely due to the repression of telomerase activity during development ( 20-23 ).”
BackgroundTelomerase activity in gastric cancer.
Hiyama, E., Yokoyama, T., Tatsumoto, N., Hiyama, K., Imamura, Y., Murakami, Y., Kodama, T., Piatyszek, M. A., Shay, J. W., & Matsuura, Y. (1995) · PubMed · Cited by 463
Self-citationTelomerase Activity in Small-Cell and Non-Small-Cell Lung Cancers
Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., & Shay, J. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.12.895 · Cited by 440
Self-citationTelomerase, Cell Immortality, and Cancer
Harley, C. B., Kim, N. W., Prowse, K. R., Weinrich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M., Greider, C. W., et al. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.035 · Cited by 396
Self-citationPiatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright, W. E., & Shay, J. W. (1995) · Methods in Cell Science · doi:10.1007/bf00981880 · Cited by 384
Self-citationTelomerase activity associated with acquisition of malignancy in human colorectal cancer.
Chadéneau, C., Hay, K. D., Hirte, H. W., Gallinger, S., & Bacchetti, S. (1995) · PubMed · Cited by 357
Counter, C. M., Botelho, F. M., Wang, P., Harley, C. B., & Bacchetti, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.3410-3414.1994 · Cited by 355
Tahara, H., Nakanishi, T., Kitamoto, M., NAKASHIO, R., Shay, J. W., Tahara, E., Kajiyama, G., & Ide, T. (1995) · PubMed · Cited by 310
Self-citationHenson, D. E., Ries, L., Freedman, L. S., & Carriaga, M. (1991) · Cancer · doi:10.1002/1097-0142(19911115)68:10<2142::aid-cncr2820681010>3.0.co;2-d · Cited by 253
DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients
Wenger, C. R., Beardslee, S., Owens, M. A., Pounds, G., Oldaker, T., Vendely, P., Pandian, M. R., Harrington, D., Clark, G. M., & McGuire, W. L. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00666351 · Cited by 169
Masood, S., Frykberg, E. R., McLellan, G. L., Scalapino, M. C., Mitchum, D. G., & Bullard, J. B. (1990) · Cancer · doi:10.1002/1097-0142(19901001)66:7<1480::aid-cncr2820660708>3.0.co;2-o · Cited by 144
Hiyama, E., Hiyama, K., Yokoyama, T., Ichikawa, T., & Matsuura, Y. (1992) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1992.tb00081.x · Cited by 104
Self-citationvan Agthoven, T., Timmermans, M. A. M., Foekens, J. A., Dorssers, L. C. J., & Henzen-Logmans, S. C. (1994) · PubMed Central · Cited by 86
Odagiri, E., Kanda, N., Jibiki, K., Demura, R., Aikawa, E., & Demura, H. (1994) · Cancer · doi:10.1002/1097-0142(19940615)73:12<2978::aid-cncr2820731215>3.0.co;2-5 · Cited by 78
Hiyama, K., Ishioka, S., Shirotani, Y., Inai, K., Hiyama, E., Murakami, I., Isobe, T., Inamizu, T., & Yamakido, M. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)90558-8 · Cited by 73
Self-citationToward a molecular understanding of human breast cancer: A hypothesis
Shay, J. W., Wright, W. E., & Werbin, H. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00662404 · Cited by 58
Self-citationALTERATION OF TELOMERIC REPEAT LENGTH IN ADULT AND CHILDHOOD SOLID NEOPLASIAS
HIYAMA, E., YOKOHAMA, T., HIYAMA, K., YAMAKIDO, M., SANTO, T., KODAMA, T., ICHIKAWA, T., & MATSUURA, Y. (1995) · International Journal of Oncology · doi:10.3892/ijo.6.1.13 · Cited by 41
Self-citationTelomerase activity in human germline and embryonic tissues and cells
Wright, W. E., Piatyszek, M. A., Rainey, W. E., Byrd, W., & Shay, J. W. (1996) · Developmental Genetics · doi:10.1002/(sici)1520-6408(1996)18:2<173::aid-dvg10>3.0.co;2-3
Self-citation
Cited by
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Self-citationBryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A., & Reddel, R. R. (1997) · Nature Medicine · doi:10.1038/nm1197-1271 · Cited by 1,292
Study, A. C., Bojesen, S. E., Study, A. O. C., Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), (GENICA), G. E. I. A. B. C., (SWE-BRCA), S. B. C. S., The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), (EMBRACE), E. S. O. B. &. B. M. C., (GEMO), G. M. O. C. R. I. B. M. C., Pooley, K. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2566 · Cited by 528
Shay, J. W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.677 · Cited by 509
Self-citationTelomerase activity, cell proliferation, and cancer
Greider, C. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.90 · Cited by 401
Metadata
- Authors
- Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., & Shay, J. W.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-01-17
- Volume
- 88
- Issue
- 2
- Pages
- 116-122
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2055618222
- Cited by
- 423
- References
- 34
- FWCI
- 38.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.